AstraZeneca: Expert discusses risk of blood clots from vaccine
When you subscribe we will use the information you provide to send you these newsletters.Sometimes they’ll include recommendations for other related newsletters or services we offer.Our Privacy Notice explains more about how we use your data, and your rights.You can unsubscribe at any time.
The blood clot controversy surrounding the AstraZeneca vaccine has deepened after it was revealed the UK trial of the Oxford-AstraZeneca will be paused following fears the vaccine puts younger people at risk of developing blood clots. The move to halt the vaccine trial is a “sensible” one, according to Professor Paul Hunter, medical microbiologist at the University of East Anglia. He said on GMB on Wednesday: “It is sensible to delay trial in children. It provides some time to understand the data better.”
Source: Read Full Article